Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 269,500 | 221,800 | 213,500 | 185,200 | 195,900 |
| Receivables | 579,100 | 542,900 | 523,400 | 494,300 | 496,400 |
| Inventories | 88,400 | 82,000 | 80,900 | 77,000 | 75,200 |
| Other current assets | 146,000 | 143,900 | 150,000 | 107,700 | 96,500 |
| TOTAL | $1,119,400 | $1,035,800 | $1,012,500 | $895,900 | $895,000 |
| Non-Current Assets | |||||
| PPE Net | 1,088,300 | 1,004,500 | 1,005,800 | 982,800 | 968,700 |
| Investments And Advances | 215,400 | 214,800 | 227,100 | 188,700 | 184,100 |
| Intangibles | 5,113,700 | 0 | 0 | 0 | 4,380,800 |
| Other Non-Current Assets | 353,201 | 5,279,300 | 5,243,200 | 4,908,200 | 448,099 |
| TOTAL | $6,770,601 | $6,498,600 | $6,476,100 | $6,079,700 | $5,981,699 |
| Total Assets | $7,890,000 | $7,534,400 | $7,488,600 | $6,975,600 | $6,876,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 101,400 | 97,300 | 92,400 | 77,200 | 73,300 |
| Accounts payable and accrued liabilities | 208,700 | 170,800 | 174,000 | 174,100 | 171,800 |
| Accrued Expenses | 60,400 | 64,900 | 63,100 | 68,600 | 73,800 |
| Other current liabilities | 253,900 | 242,200 | 222,300 | 203,500 | 204,100 |
| TOTAL | $624,400 | $575,200 | $551,800 | $523,400 | $523,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,268,900 | 3,094,200 | 3,039,700 | 2,793,800 | 2,701,800 |
| Other Non-Current Liabilities | 699,200 | 715,000 | 676,900 | 583,800 | 569,700 |
| TOTAL | $4,069,200 | $3,847,300 | $3,760,500 | $3,414,300 | $3,319,200 |
| Total Liabilities | $4,693,600 | $4,422,500 | $4,312,300 | $3,937,700 | $3,842,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 127,613 | 127,114 | 127,124 | 127,094 | 126,607 |
| Common Shares | 1,300 | 1,300 | 1,300 | 1,300 | 1,300 |
| Retained earnings | -737,300 | -628,800 | -597,100 | -581,600 | -569,200 |
| Other shareholders' equity | 1,411,500 | 1,225,900 | 1,261,000 | 1,122,600 | 1,104,800 |
| TOTAL | $3,196,400 | $3,111,900 | $3,176,300 | $3,037,900 | $3,034,500 |
| Total Liabilities And Equity | $7,890,000 | $7,534,400 | $7,488,600 | $6,975,600 | $6,876,700 |